Neutrogena Oil-Free Acne Wash Pink Grapefruit Foaming Scrub

Description

Oil-Free Acne Wash is a pink grapefruit foaming scrub formulated with MICRO CLEAR® technology, designed to effectively clear breakouts. This product contains naturally derived grapefruit extract and utilizes salicylic acid as an active acne treatment. It is packaged in a 6.7 FL.OZ. (198 mL) container and is marketed under the Neutrogena® brand.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to instruct patients to cleanse their face twice daily. The cleansing process should begin with wetting the face. A sufficient amount of the cleanser should be applied to the hands, followed by the addition of water to create a lather. The lather should then be gently massaged onto the face to ensure effective cleansing. It is essential to rinse the face thoroughly with water after massaging to remove all residues of the cleanser.

Contraindications

There are no specific contraindications listed for this product.

It is advised to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Additionally, avoid contact with eyes; if contact occurs, flush thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation occurs, it is recommended to limit the use to one topical acne medication at a time to minimize adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to flush the eyes thoroughly with water to mitigate any potential irritation or damage.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The most common adverse reactions reported include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

In the event of contact with the eyes, patients should flush the area thoroughly with water to alleviate any potential discomfort. Additionally, it is crucial to keep this product out of reach of children. If the product is swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil-Free Acne Wash Pink Grapefruit Foaming Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Neutrogena Oil-Free Acne Wash Pink Grapefruit Foaming Scrub in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be applicable to elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient circumstances when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of the patient's response to treatment.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no available data regarding its safety or efficacy during pregnancy. Consequently, there are no established dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of information when prescribing this product to women of childbearing potential and weigh the potential risks and benefits. It is advisable to counsel patients regarding the absence of data and to monitor for any adverse effects should the product be used during pregnancy.

Lactation

The safety of this product during lactation has not been established. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. In the event of accidental contact, patients should be instructed to flush the eyes thoroughly with water.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The product is administered topically and should be applied twice a day. Clinicians should advise patients that the medication is for external use only and caution them about the potential for skin irritation and dryness, particularly if used concurrently with other topical acne treatments. In the event of irritation, patients are recommended to limit use to one topical acne medication at a time.

Patients should also be instructed to avoid contact with the eyes; if contact occurs, they should flush the area thoroughly with water. Additionally, the product should be kept out of reach of children, and in the case of accidental ingestion, medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil-Free Acne Wash Pink Grapefruit Foaming Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)